← Eichor
Condition: Urinary Bladder Overactive Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Urinary Bladder Overactive

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA
Phase 4 · 1 location(s) · Atlantic Health System · NCT05519072Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
Phase 2/Phase 3 · 1 location(s) · Northwestern University · NCT05878951Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
Phase 4 · 1 location(s) · Walter Reed National Military Medical Center · NCT04020510Effects of Microbiological and Immunological Factors on the Lower Urinary Tract
Phase N/A · 1 location(s) · University of Zurich · NCT07494864Noninvasive Ultrasound Assessment of Detrusor Dysfunction
Phase N/A · 1 location(s) · Mayo Clinic · NCT05652023Add-On ZIDA Sock Therapy for Overactive Bladder
NA · 1 location(s) · Medical University of South Carolina · NCT07432659Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder
Phase 4 · 1 location(s) · Mackay Memorial Hospital · NCT06479720Antibiotic Usage Prior to OnabotulinumtoxinA Injection
NA · 1 location(s) · Benaroya Research Institute · NCT04754737Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
NA · 15 location(s) · FemPulse Corporation · NCT07195656Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome
Phase 4 · 1 location(s) · Walter Reed National Military Medical Center · NCT05221021Oral Lactobacillus Supplementation as Treatment for Overactive Bladder Syndrome: A Randomised Controlled Trial
NA · 1 location(s) · Medical University of Vienna · NCT06546189Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Wome
Phase 4 · 14 location(s) · Mansoura University · NCT07416968Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial
NA · 1 location(s) · Benha University · NCT07184307Effects of Sacral and Tibial Stimulation on Bladder Function in Subacute Suprasacral Spinal Cord Injury
NA · 1 location(s) · Ankara City Hospital Bilkent · NCT07343583Percutaneous Nerve Evaluation Trial Time
NA · 1 location(s) · University of Chicago · NCT06226220Intradetrusor Onabotulinumtoxin A (Botox) at the Time of Transurethral Resection of the Prostate or Transurethral Waterj
Phase N/A · 1 location(s) · Benaroya Research Institute · NCT07377929Safety and Performance of UCon Patch Electrode
NA · 3 location(s) · InnoCon Medical · NCT06754189Bladder Botox UTI Antibiotic Prophylaxis
Phase 4 · 1 location(s) · Walter Reed National Military Medical Center · NCT06387329PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB
NA · 5 location(s) · Axonics, Inc. · NCT06789406Aquarius Pilot Study to Evaluate the New Axonics Trial System
NA · 2 location(s) · Axonics, Inc. · NCT07335484NXT Post-Market Clinical Follow-up
Phase N/A · 5 location(s) · Laborie Medical Technologies Inc. · NCT06336304Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children
NA · 4 location(s) · Aalborg University Hospital · NCT05989646Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet
NA · 1 location(s) · Children's Hospital of Chongqing Medical University · NCT06201013Predictive Utility and Mechanisms of Sacral Evoked Responses in Sacral Neuromodulation
NA · 1 location(s) · University of Michigan · NCT06983470UCon Treatment of Overactive Bladder (OAB) in Males
NA · 1 location(s) · InnoCon Medical · NCT05874375Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
NA · 1 location(s) · Loma Linda University · NCT04527445Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)
Phase 3 · 5 location(s) · University of Aarhus · NCT06551246Ambulatory Long Length URodynamics Evaluation
NA · 7 location(s) · Bright Uro · NCT07425015Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder
NA · 1 location(s) · Yin Ping · NCT05798403Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients
Phase N/A · 4 location(s) · University Hospital Ostrava · NCT06921746
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.